Hypothermic Oxygenated Perfusion Versus Normothermic Regional Perfusion in Liver Transplantation From Controlled Donation After Circulatory Death

Xavier Muller(Université Claude Bernard Lyon 1), Kayvan Mohkam(Université Claude Bernard Lyon 1), Matteo Mueller(University Hospital of Zurich), Andrea Schlegel(University Hospital of Zurich), Fédérica Dondero(Hôpital Beaujon), Ailton Sepulveda(Hôpital Beaujon), Éric Savier(Sorbonne Université), Olivier Scatton(Sorbonne Université), Petru Bucur(Centre Hospitalier Universitaire de Tours), Ephrem Salamé(Centre Hospitalier Universitaire de Tours), Heithem Jeddou(Hôpital Pontchaillou), Laurent Sulpice(Hôpital Pontchaillou), Gabriella Pittau(Université Claude Bernard Lyon 1), Marc‐Antoine Allard(Université Claude Bernard Lyon 1), Jean‐Yves Mabrut(Université Claude Bernard Lyon 1), Philipp Dutkowski(University Hospital of Zurich), Pierre‐Alain Clavien(University Hospital of Zurich), Mickaël Lesurtel(Université Claude Bernard Lyon 1)
Annals of Surgery
August 21, 2020
Cited by 69

Abstract

OBJECTIVE: To compare HOPE and NRP in liver transplantation from cDCD. SUMMARY OF BACKGROUND DATA: Liver transplantation after cDCD is associated with higher rates of graft loss. Dynamic preservation strategies such as NRP and HOPE may offer safer use of cDCD grafts. METHODS: Retrospective comparative cohort study assessing outcomes after cDCD liver transplantation in 1 Swiss (HOPE) and 6 French (NRP) centers. The primary endpoint was 1-year tumor-death censored graft and patient survival. RESULTS: A total of 132 and 93 liver grafts were transplanted after NRP and HOPE, respectively. NRP grafts were procured from younger donors (50 vs 61 years, P < 0.001), with shorter functional donor warm ischemia (22 vs 31 minutes, P < 0.001) and a lower overall predicted risk for graft loss (UK-DCD-risk score 6 vs 9 points, P < 0.001). One-year tumor-death censored graft and patient survival was 93% versus 86% (P = 0.125) and 95% versus 93% (P = 0.482) after NRP and HOPE, respectively. No differences in non-anastomotic biliary strictures, primary nonfunction and hepatic artery thrombosis were observed in the total cohort and in 32 vs. 32 propensity score-matched recipients CONCLUSION:: NRP and HOPE in cDCD achieved similar post-transplant recipient and graft survival rates exceeding 85% and comparable to the benchmark values observed in standard DBD liver transplantation. Grafts in the HOPE cohort were procured from older donors and had longer warm ischemia times, and consequently achieved higher utilization rates. Therefore, randomized controlled trials with intention-to-treat analysis are needed to further compare both preservation strategies, especially for high-risk donor-recipient combinations.


Related Papers

No related papers found

Powered by citation graph analysis